Mental health provider Braxia Scientific to acquire KetaMD for $6 million
KetaMD is a telehealth platform that provides affordable, home-based ketamine treatment for people with anxiety, depression, and related mental illnesses. Treatment provided by KetaMD is medically supervised, directed by registered nurses with expertise in mental health, and supported by psychiatrists and depression researchers. The company applies ketamine to telemedicine, following best practices and professional treatment […]
Mental health provider Braxia Scientific to acquire KetaMD for $6 million Read More »